Immunotherapies Based on PD-1/PD-L1 Pathway Inhibitors in Ovarian Cancer Treatment

Clinical and Experimental Immunology - United Kingdom
doi 10.1111/cei.13255
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley